Human Genome Epidemiology Literature Finder
Records 1 - 1 (of 1 Records) |
Query Trace: Disease Progression and PKHD1[original query] |
---|
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11). Breast cancer research and treatment 2019 8 178 (2): 367-377. Kim Ji-Yeon, Lee Eunjin, Park Kyunghee, Im Seock-Ah, Sohn Joohyuk, Lee Keun Seok, Chae Yee Soo, Kim Jee Hyun, Kim Tae-Yong, Jung Kyung Hae, Park Yeon Hee, |
- Page last reviewed:Feb 1, 2024
- Content source: